Literature DB >> 32411502

Evaluation of super-responders to cardiac resynchronization therapy in the presence of left bundle branch block and absence of scar in the posterolateral wall of the left ventricle.

Izaias Marques de Sá Junior1, José Carlos Pachón Mateos1, Juan Carlos Pachón Mateos1, Remy Nelson Albornoz Vargas1.   

Abstract

Patients with heart failure (HF) undergoing cardiac resynchronization therapy (CRT) who exhibit above-expected improvement are known as super-responders. We assessed the rate of super-responders in a population with left bundle branch block (LBBB) > 150 ms in the absence of scar tissue in the left ventricular posterolateral wall as well as prognostic variables. In this prospective observational cohort study (n=20) an electrocardiogram (ECG) was performed pre- and post-CRT. The classic and Strauss LBBB criteria were adopted (> 150 ms). The percent (%) reduction of the QRS was calculated after implantation. All patients responded to the Minnesota Living with Heart Failure questionnaire and underwent an echocardiogram to measure left ventricular ejection function (LVEF), left atrium (LA) diameter, left ventricular end-systolic volume (LVEDV), left ventricular end-diastolic volume (LVESV), and left ventricular end-diastolic diameter (LVEDD) pre- and 6 months post-CRT. Cardiac magnetic resonance imaging (MRI) measured the presence of scar tissue in the posterolateral LV wall and the total scar burden (% LV mass). Fisher's exact test and the Mann-Whitney test were performed to evaluate possible prognostic variables. The mean age was 58.20±8.79 years old, 60% female, with a mean LVEF of 28.15±5.10%, ECG with LBBB mean QRS of 162.15±7.86 ms, LBBB > 150 ms with Strauss standard in 90% of cases, and 90% with non-ischemic cardiomyopathy. Twelve cases (60%) of super-responders (reduction > 30% LVESV after 6 months) were observed. Super-responders did not present a difference in response in sex (12 vs 8 P=0.67), age (58.67 vs 57.7 P=087), Minnesota quality of life (55.50 vs 67.70 P=0.2), % initial QRS reduction (21.16 vs 18.69 P=0.21), LVEF (29.25 vs 26.5 P=0.38), LVEDD (66.33 vs 67.67 P=0.83), LVEDV (211.16 vs 228.53 P=0.75), LVESV (145.83 vs 167.00 P=0.75), or LA diameter (41.58 vs 43.63 P=0.45). The presence of LBBB > 150 ms, using the Strauss standard (90%) and the absence of scar in the posterolateral wall may account for these positive results. Super-responders benefit the most from CRT, and the results of this study can contribute to a better selection of CRT candidates. AJCD
Copyright © 2020.

Entities:  

Keywords:  Congestive heart failure; cardiac resynchronization therapy; left bundle branch block; myocardial scar; super-responders

Year:  2020        PMID: 32411502      PMCID: PMC7218684     

Source DB:  PubMed          Journal:  Am J Cardiovasc Dis        ISSN: 2160-200X


  38 in total

1.  Delayed enhancement magnetic resonance imaging predicts response to cardiac resynchronization therapy in patients with intraventricular dyssynchrony.

Authors:  James A White; Raymond Yee; Xiaping Yuan; Andrew Krahn; Allan Skanes; Michele Parker; George Klein; Maria Drangova
Journal:  J Am Coll Cardiol       Date:  2006-10-31       Impact factor: 24.094

2.  Late gadolinium enhancement-cardiovascular magnetic resonance as a predictor of response to cardiac resynchronization therapy in patients with ischaemic cardiomyopathy.

Authors:  Shajil Chalil; Paul W X Foley; Sarkaw A Muyhaldeen; Kiran C R Patel; Zaheer R Yousef; Russell E A Smith; Michael P Frenneaux; Francisco Leyva
Journal:  Europace       Date:  2007-10-12       Impact factor: 5.214

3.  2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

Authors:  Michele Brignole; Angelo Auricchio; Gonzalo Baron-Esquivias; Pierre Bordachar; Giuseppe Boriani; Ole-A Breithardt; John Cleland; Jean-Claude Deharo; Victoria Delgado; Perry M Elliott; Bulent Gorenek; Carsten W Israel; Christophe Leclercq; Cecilia Linde; Lluís Mont; Luigi Padeletti; Richard Sutton; Panos E Vardas
Journal:  Europace       Date:  2013-06-24       Impact factor: 5.214

4.  Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials.

Authors:  Ilke Sipahi; Thomas P Carrigan; Douglas Y Rowland; Bruce S Stambler; James C Fang
Journal:  Arch Intern Med       Date:  2011-06-13

Review 5.  Cardiac resynchronization therapy in patients with postero-lateral scar by cardiac magnetic resonance: A systematic review and meta-analysis.

Authors:  Amin Daoulah; Alawi A Alsheikh-Ali; Salem M Al-Faifi; Sara R Ocheltree; Ejazul Haq; Farhan M Asrar; Adnan Fathey; Ali Ahmed Haneef; Faris Al Mousily; El-Sayed O; Amir Lotfi
Journal:  J Electrocardiol       Date:  2015-06-19       Impact factor: 1.438

6.  Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.

Authors:  Jonathan C Hsu; Scott D Solomon; Mikhail Bourgoun; Scott McNitt; Ilan Goldenberg; Helmut Klein; Arthur J Moss; Elyse Foster
Journal:  J Am Coll Cardiol       Date:  2012-06-19       Impact factor: 24.094

7.  Predictors for restoration of normal left ventricular function in response to cardiac resynchronization therapy measured at time of implantation.

Authors:  Laura Vitali Serdoz; Elisabetta Daleffe; Marco Merlo; Massimo Zecchin; Giulia Barbati; Domenico Pecora; Bruno Pinamonti; Cecilia Fantoni; Pierpaolo Lupo; Andrea Di Lenarda; Gianfranco Sinagra; Riccardo Cappato
Journal:  Am J Cardiol       Date:  2011-04-29       Impact factor: 2.778

8.  Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis.

Authors:  Rutger J van Bommel; Jeroen J Bax; William T Abraham; Eugene S Chung; Luis A Pires; Luigi Tavazzi; Peter J Zimetbaum; Bart Gerritse; Nina Kristiansen; Stefano Ghio
Journal:  Eur Heart J       Date:  2009-08-30       Impact factor: 29.983

9.  Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy.

Authors:  Gabe B Bleeker; Theodorus A M Kaandorp; Hildo J Lamb; Eric Boersma; Paul Steendijk; Albert de Roos; Ernst E van der Wall; Martin J Schalij; Jeroen J Bax
Journal:  Circulation       Date:  2006-02-13       Impact factor: 29.690

10.  Cardiac resynchronization therapy: "nonresponders" and "hyperresponders".

Authors:  Philippe Castellant; Marjaneh Fatemi; Valerie Bertault-Valls; Yves Etienne; Jean-Jacques Blanc
Journal:  Heart Rhythm       Date:  2007-10-02       Impact factor: 6.343

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.